Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Brazil trials are going and it is the 13d desperados that are done. With positive interim results from Brazil the 13d will be fried to a crisp.
The true market value if CYDY. I calculate as $7 billion. This is currently with many unknowns. On first approval likely $30 to $50 Billion.
(Don't Blink!)
Who wants to sell for cheap?
The 13D Group is a RICO in sheep's clothing. The pigs are at the trough when the money is green.
Shorts key on confustion and the 13D Group are penultimately confused and deluded.
Racketeering in the stock market and Wall Street is quasi legal because it is not enforced. SEC my ass. They protect the RICOs.
CytoDyn will succeed because Dr Nadar Pouhassan is no body's bitch.
Those that are accumulating now are buying diamonds or platinum for the price of iron or more fitting the price of graphite before the passage of time and tremendous pressure of a Regulatory milestone turns this lump of anthracite into high performance industrial diamonds.
In the pandemic maybe they did not want to keep the potential EUA patients in the hospital 28 days. They wanted something that they would get out of the hospital in 14 days one way or the other. Hence Remdis.vir
What the short sellers do not understand is the demographics and investment styles of the majority of retail investors in CYDY. They are counting on hot money retail that will sell back to them so they can cover at $4 $5 $6 $7 $10 to cash out so they are not totally destroyed when CYDY recovers. However the demographics of the LONGs are old and experienced relatively wealthy and not likely to sell much stock even over $10 because they are long term investors and know what they own. After the Fire Missling campaign failed for many of these same group of short sellers that stock shot of 25 X at its peak. Same demographics for CYDY. There simply will not be enough shares for shorts to cover CYDY short sells much under 20X or $30 per share. A BP partnership for CYDY will instantly wipe them out. Absent a BP partnership short sellers might be painfully ground down by inextricable slow and methodical advancing clinical development.
I am completely comfortable with my investment in CYDY as I and most Longs are experienced long term investors who do not need the money and do not flip stocks for short term gains. I have my percentage of CYDY and I never intend to sell, ever. I expect one day many years from now to have dividends per share on a quarterly basis that exceed my cost basis per share of CYDY.
The Dow BellWeather AeroSpace giant until recently did just that same thing to long term holders of its stock. Twenty year hold periods in major oil giants have done so as well. Generational wealth creation is something the "get rich quick" short selling or stock flipper crowd do not understand.
The only ones that support the 13 D group are the anti-CYDY crowd.
No thanks I will just use the $7500 and much much more to buy more CYDY and vote those shares against 13D. I buy that much every month and lately every week. Thank you 13 DBs for helping me accumulate many more shares at a ridiculously low price. I was set for life from the last heavily bashed biotech by buying hand over fist during the "Fire CEO Missling" short bashing. CYDY has a geometrically larger potential than that other favorite investment of mine. It was a 20x bagger after the Fire Missling short campaign. I am solidly expecting even better results from CYDY in as short as 6-9 months.
Don't blink. If one had blinked on Christopher Missling they would have missed on generational wealth creation. Still no approval or pivotal trail results but is 15x the price just a short time ago.
I certainly do not want CYDY to raise money in the legal ripoff of shareholders way that HGEN did. HGEN shares were sold in a private offering those hedge funds had prior knowledge of the amount and price of the HGEN shares. WITH THAT KNOWLEGE THEY WERE LEGALLY ALLOWED TO SHORT HGEN SHARES PRIOR TO THE OFFERING THEN COVER THE SHORT SALES WITH THE OFFERING SHARES. That is perfectly legal but favors the hedge funds over the existing HGEN shareholders. HGEN will do it again it is an insiders club and retail HGEN are not invited.
You obviously spout off your opinions without determining the facts by reading the SEC filings. At least one of the Directors has been buying on the open market for years including during the past year.
That seems much more than shady. That sounds like out and out inducement by false promises to invest in a private enterprise. Private investments like that can only be pitched to investors that the hedge fund has affirmatively qualified as an accredited investor. Then the part about pitching InCellDx as potentially valuable because a third party will "take over" CytoDyn could be ruled a fraudulent inducement. Looks like the 13D group, Patterson. InCellDX and that Hedge fund may be facing a lot of potential litigation from InCellDX investors and possibly the DOJ for criminal charges. F...ing ouch for them.
This is an unsupported option not based in reality. There was enough volume after hours for the stock to be in equilibrium so it should start trading at the premarket price. Unless the 11% short position is has already covered it is likely to recover somewhat as profits are taken by buying stock to close short positions on Monday.
Exactly correct. This is an excellent opportunity to accumulate a greater than 5x bagger in 9 to 18 months. Accerated approval is still operative so once these issues are worked out it will be a near lock for approval in a compressed time span.
It not political. It is racketeering. The new CDER head is a BP Rackteer plant. GILD recently was fined for bribery and kick backs to promote its drugs before the pandemic. Then its worthless drug was given green light by FDA even though it failed all the trials and most all other Covid therapudics were systematically suppressed.
Biogen is the poster boy for price gouging. Then its worthless and harmful drug Aduhelm was approved by FDA over objections of the Independent Scientific Advisory panel. The two biggest RICOs in BP are being given free rein due to the corruption they induce with legal lobbying and illegal inducements.
FDA bends the rules in favor of the RICOs due to racketeering and overly enforces them against those smaller companies that are outside if the inner circle of the corrupt system.
Bottom line I own a lot of SESN at well under a buck and added a boat load more under $1.60. The CRL will allow me to add more until the manufacturing issues are worked out. There was no questions regarding efficacy or safety. Those are the difficult hurdles and have been cleared. The issues of the CRL will be overcome and SESN has a boatload of cash to see this through. Approval will eventually be granted.
That tells me your brokerage is most likely Fidelity or possibly Schwab.
One would have to be really out of touch to not understand some of the most important International NGOs in regards to World Health are based in Malta.
Simple. The USA trials they publicly commented on were under powered Phase 2 trials. Now if we get the good and expected results from Brazil they can grant appropriate EUA in USA based on the Brazil results pending a USA Phase 3 designed as a registational trial for full approval. Then all of a sudden FDA goes from pariahs to heros for bringing forth Leronlimab in the pandemic. The Administration's Vaccine goals could also be advanced by using Leronlimab in trials as an adjuvant with the soon to be fully approved vaccines hoping to show greatly increased safety and effectiveness of the vaccine against Delta and Lambda Covid variants. The adjuvant use of Leronlimab with vaccines could be the absolute largest market for the drug. This has not been explored as vaccines are not fully approved yet.
Sleep on that shorts...if you can!
All of that is moot with the Brazil trial approval. Watch how fast the US FDA changes its tune when the Brazil results come in.
The interim results at 40% possibly in October might smash the endpoints so convincingly that the whole World will see that approval is near certain.
The idea that the USA FDA is dictating to other countries Regulatory Agencies against Leronlimab is so extremely unlikely as to be the farthest fetched notion ever. CYDY ran two Phase 2 trials in USA approved by USA FDA. They have the money to run 2 Phase 3 trials. The best CRO available was the Albert Einstein Hospital Group in Brazil which also had the most patients for the trials. They chose wisely Brazil over USA or the Philippines or anywhere else. If the Brazil trials prove the hypothesis generated by the Phase 2 trial Leronlimab will be golden in the eyes of the US FDA and everybody else including Big Pharma.
Anyone that remembers the way everybody and their dog talked about and wanted Cisco Systems shares in 1999 might see a repeat of that after CYDY is generating boatloads of cash from Covid, TNBC and HIV. And rightly so as Leronlimab has the potential in so many areas of medicine that deal with CCR5 and inflammation that it could be such a critical piece of the puzzle in medicine as Cisco switches and modems were to the Internet.
Why on earth else would there be the greatest of kerfuffles over CYDY? Because it is perceived to be the greatest potential disruptor in medicine. The great kerfuffle over the drug A2-73 and the SigmaOne receptor while maybe the greatest amount of kerfuffle before this Leronlimab and CCR5 kerfuffle pales in magnitude to the CYDY battle. Because although blarcamesine is a "pearl of inestimable value" and immense potential in CNS unmet need Leronlimab could be "the whole pearl bed of inestimable pearls" in many of the most chronic and pernicious afflictions that involve inflammation and dysfunctional immune response including ALZ.
BTW the baby bio that owns blarcamesine finally shot up recently 20X to above $25 from a low at $1.26 in Dec 2018 after being share price suppressed for many years under the kurfuffle mantra "Fire CEO Missling".
Sound familiar? Exact same tactics are being used against CYDY but with even louder and shriller fervor.
Don't blink!
Sorry to hear about your son Doctor. My prayers that he will pull through.
Awesome. The potential of Leronlimab is tremendous in many areas of medicine.
I believe you are confused. Subpoenas do not need probable cause. Subpeonas are not issued to targets of investigations as it would be a violation of constitutional rights. Targets must be issued warrants not subpeonas. Warrants require probable cause. The fact that CYDY was issued subpeonas mean that CYDY is not the target of the investigation.
The 13D group lawyers just got "Swartzkoffed" by the Sidley Austin Law Firm.
Wait until the Shorts get a load of the news that the Approved Trial in Brazil is nearly complete enrollment because of the waiting list. All the loved ones of prominent Brazillians among the interim readout within weeks of today will be clamoring for immediate EUA in Brazil if results are as good as indicated in the subset defined by the previous trials. You know that data that the FDA called "hypothesis generating"
Eye of the Jaguar!
That would be an awesome buying opportunity. I would sell gold and divvy generating blue chips to get a lot of that action.
Most likely that without a substantial news item it will continue to base here which to me is a very good opportunity to accumulate weekly. I have patience and always welcome lower prices for high potential stocks as I never invest with a less than 5 year expected hold period. Set backs always happen in biotech and are some of the best time to make signicant accumulations.
CYDY is a possible 3x or more bagger in less than a year and a further 10-15x
bagger from there within 5 years.
Prior to CYDY the most heavily bashed biotech was "Little Orphan Ana_ _ _" Which fell to $1.26 in December 2018 during the "Fire CEO Missling" bashing fervor. It rose 15x plus in 18 months recently trading $20.00 plus but still no major catalyst like an approval or even readout on its most important trials.
So yes all yee naysayers keep screeching "Fire Nader" as I accumulate further while building a long term position.
AF and all those prolific all day all night naysayers were dead wrong on that one and they are dead wrong about CytoDyn.
CYDY has run out of time for what? Your statement or musing makes no sense.
If there are any thing negative after May 1st CYDY would have had to report it in a 8K. Nothing happened bad to CYDY. That is a fact.
Welcome to the anti-CYDY pro 13D echo chamber. Often the best investment opportunities are presented when sentiment is at its lowest. Accumulating here.
Why if CYDY has nothing are so many vocal opponents aligned against CYDY. The last time that happened in one of my investments it was a 15x plus bagger in 18 months and still not an FDA approval in that stock. Stand by and be patient people.
That may have been the 1 million shares ANVS sold at $50 on May 21st taking profits on that position. Hence the drop to $50. Those shares are likely distributed to other investors now and will gradually move back up.
Interesting and enlightening discussion of what appears to be racketeering in shares of CYDY stock by members of the 13D group in parallel with the racketeering of Citron and Sykes.
This post perfectly explains the rational for delaying TLD to coincide with the coming journal publication.
This post definitely deserves and should be elavated to a sticky post.
Why no leaks? I suspect that their will be many involved that are compensated in shares of NWBO and others are simply in awe of the data and consider themselves as being professionally rewarded by their contributions to this effort which may be the crowning glory of their life's work.
I pitty those that sold their shares of CYDY.
I agree with most of this post, however the already complicated negotiations regarding a partnership would never be complicated with a thoroughly impractical and impossible condition that the Share price of the junior partner reach a certain level otherwise neither partner would have any reasonable hope of concluding the deal. Could NWBO conceal a partnership until the price reached a certain level? Doubtful and why on Earth would they want to? Share price is irrelevant to partnering negotiations in most instances, one would think. CPXX was trading at $1.36 when its results were released and it shot to $20 plus and was bought out for $30 plus sixty days later.
Gilead recently bought out a cancer company with a failed Phase 2 trial of its lead drug for $20 billion. So yes I agree $30 Billion is the floor of what NWBO would demand for a buyout if TLD results are good as we expect.
If Anvista delivered an unfavorable decision CYDY must disclose in a SEC 8k filing in a few days. If it is favorable they could delay but would not likely do so.
Well done Bio. You maintain a positive and rational stance in the face of emotional displays of the negative posts.
Luckily this 13D group is still on the outside. Doubtful that they will be successful in their planned coup. It seems individually and a group that they are unethical under acheivers.
So the 13d group that poses as a white knight may be a group of assassins?
Looking to double my already large position between now and October. I am accelerating accumulation at these low prices.
Where CYDY is today is they expended a huge amount of energy to fight a battle like Guadalcanal. The phase 2 trials early battle was to take a staging area to move the battle forward. Lots of casualties to share price but Phase 2 Guadalcanal taken. Time to build the air base and move the battle forward. This is not time to give up and change directions. Objective taken Time to move forward.